A Message from our CEO/Executive Director
Greetings and Happy New Year!
A Tribute to Debbie Markham
David and Goliath.
This is an ironic time of year.
It’s so amazing how quickly summer seemed to fly by.
“The dog days of summer”
How did it get to be June so quickly?
May 7th we are excited to host our Ribbons and Roses fundraiser at the Lamar Street Center.
“There is no luck except where there is discipline.”
The Dalai Lama once said “Love and compassion are necessities, not luxuries. Without them, humanity cannot survive.”
We couldn’t do this important work without you – thank you very much!
WSCR-NCORP is putting compassion first with the creation of our Implicit Bias in Healthcare steering committee.
Dear Friends of Western States Cancer Research NCORP,
As an NCORP, (The NCI Community Oncology Research Program (NCORP) we are an affiliate of the NCI. The NCORP is a national NCI-supported network that brings cancer clinical trials and care delivery studies to people in their communities.
Being an NCORP allows us to offer unique opportunities to not only bring clinical trials in community settings but also to conduct care delivery research (CCDR) where the majority of cancer patients receive their treatment.
Cancer Care Delivery Research (CCDR) is a multidisciplinary science that seeks to improve clinical outcomes and patient well-being by intervening on patient, clinician, and organizational factors that influence care delivery.
Integrating care delivery research within the NCORP network provides the ability to collect primary data and initiate interventions; look across a mix of practice models and heterogeneous populations and follow patients from time of diagnosis through treatment and survivorship.
The goal of CCDR in NCORP is to generate evidence that can be used to improve clinical practice, particularly through the evaluation of pragmatic interventions focused on clinicians, staff, and/or practices. In other words, CCDR studies focus on the how cancer affects patients and their caregivers/ families, rather than studying the cancer itself. Those studies look at issues such as financial toxicity; emotional enhancements to support patients on their cancer journeys; and identification of structural, systemic, and psychosocial barriers to adherence to studies, to name a few.
We, at Western States, are committed to bringing patients the broadest array of available options when patients receive a cancer diagnosis, and we are proud to be able to bring NCI trials that support them and their families with a full spectrum of cancer care.
If you or someone you know is interested in learning more about CCDR studies, or any of our NCI studies, please do not hesitate to call our office at 303.777.2663.
Many thanks for your support.
To your good health,